ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,176.69
-0.02%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Bio Techne Corporation (TECH)

  7. Bio Techne Corporation (TECH) Noticias

TECH Bio Techne Corporation

75.87
-1.01 (-1.31%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bio Techne Corporation TECH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-1.01 -1.31% 75.87 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
76.50 74.79 77.02 75.87 76.88
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
31/5/202406:00EDGAR2Form SD - Specialized disclosure report
31/5/202406:00PRNUSBIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
30/5/202406:00PRNUSBIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE..
29/5/202406:00PRNUSScaleReady Announces $20 Million G-Rex® Grant Program for..
23/5/202406:00PRNUSBIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS..
22/5/202406:00PRNUSBIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER..
16/5/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202415:10EDGAR2Form 144 - Report of proposed sale of securities
08/5/202406:00PRNUSBIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE..
07/5/202406:00PRNUSBIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE..
01/5/202405:30PRNUSBIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
30/4/202406:00PRNUSBIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF..
29/4/202406:00PRNUSBIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO..
26/4/202406:00PRNUSBIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR..
23/4/202406:00PRNUSBIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST..
10/4/202406:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO..
08/4/202406:00PRNUSBIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS..
03/4/202406:00PRNUSBIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR..
01/4/202406:00PRNUSBIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR..
28/3/202408:00PRNUSBIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP..
22/3/202406:00PRNUSBIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR..
12/3/202406:00PRNUSBIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH..
11/3/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202414:03EDGAR2Form 144 - Report of proposed sale of securities
06/3/202406:00PRNUSBIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL..
07/2/202415:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/2/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202417:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/2/202417:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202405:30EDGAR2Form 8-K - Current report
29/1/202406:00PRNUSBIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW..
25/1/202406:00PRNUSLUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH..
24/1/202406:00PRNUSSCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN..
16/1/202406:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO..
08/1/202405:32EDGAR2Form 8-K - Current report
05/1/202406:00PRNUSBIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS..
04/1/202406:00PRNUSBIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING..
21/12/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:00PRNUSBIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN..
20/12/202306:00PRNUSBIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR..
14/12/202317:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
14/12/202306:00PRNUSLUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP..
27/11/202306:00PRNUSBIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI..
13/11/202306:00PRNUSBIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
07/11/202315:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202317:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202317:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202306:00PRNUSASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023..

Su Consulta Reciente

NASDAQ
TECH
Bio Techne
EU
EMSA
iShares JP Morgan ESG EM...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados